breast Z12.31 (mammogram) (routine) ICD-10-CM Codes Adjacent To Z12.31 Z11.9 Encounter for screening for infectious and parasitic diseases, unspecified
2018/2019 ICD-10-CM Diagnosis Code R92.8. Other abnormal and inconclusive findings on diagnostic imaging of breast. R92.8 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Breast lesions found by mammogram and classified as probably benign by BI-RADS should have follow-up imaging at or before 6 months after the lesions are found to ensure that the lesions are not cancer, according to a study. The research was published online on May 19, 2020, by the journal Radiology .
Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm. Z09 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2020 edition of ICD-10-CM Z09 became effective on October 1, 2019.
Z12. 31, Encounter for screening mammogram for malignant neoplasm of breast, is the primary diagnosis code assigned for a screening mammogram. If the mammogram is diagnostic, the ICD-10-CM code assigned is the reason the diagnostic mammogram was performed.
Z12. 31 (Encounter for screening mammogram for malignant neoplasm of breast) is reported for screening mammograms while Z12. 39 (Encounter for other screening for malignant neoplasm of breast) has been established for reporting screening studies for breast cancer outside the scope of mammograms.
Breast lesions found by mammogram and classified as probably benign by BI-RADS should have follow-up imaging at or before 6 months after the lesions are found to ensure that the lesions are not cancer, according to a study.
Z09 ICD 10 codes should be used for diseases or disroder other than malignant neoplasm which has been completed treatment. For example, any history of disease should be coded with Z08 ICD 10 code as primary followed by the history of disease code.
A screening colonoscopy should be reported with the following International Classification of Diseases, 10th edition (ICD-10) codes: Z12. 11: Encounter for screening for malignant neoplasm of the colon.
For example, Z12. 31 (Encounter for screening mammogram for malignant neoplasm of breast) is the correct code to use when you are ordering a routine mammogram for a patient. However, coders are coming across many routine mammogram orders that use Z12. 39 (Encounter for other screening for malignant neoplasm of breast).
ICD-10 code R92. 8 for Other abnormal and inconclusive findings on diagnostic imaging of breast is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
Short-interval follow-up mammography monitors lesions for changes at a more frequent interval than regular screening and is intended to serve as an alternative to invasive procedures, such as biopsy or fine-needle aspiration [1, 10].
A BI-RADS category 2 at the end of your report means that the mammogram, breast ultrasound and/or MRI breast show benign findings, not suspicious findings for cancer. With a final report of BI-RADS category 2, you can continue to go for normal, annual screenings if you are of average risk and over the age of 40.
Following ICD-10 guidelines, if a patient has or has had an HIV related condition, use B20 AIDS. If the patient has a positive HIV status, without symptoms or related conditions, use Z21.
ICD-10 code Z08 for Encounter for follow-up examination after completed treatment for malignant neoplasm is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Z09 is an appropriate first-listed code and completely acceptable by payers.